Analyst Expectations for Ionis Pharmaceuticals's Future
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for Ionis Pharmaceuticals (NASDAQ:IONS) in the last quarter. In the last 3 months, 4 analysts have offered 12-month price targets for Ionis Pharmaceuticals, with an average price target of $56.25, an increase of 44.23% from the previous average price target of $39.00.
September 27, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have provided bullish ratings for Ionis Pharmaceuticals, with an increased average price target of $56.25.
The bullish ratings and increased price target indicate a positive outlook for Ionis Pharmaceuticals. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100